doi:10.3969/j.issn.1673-8640.2015.11.015

Abstract

CLC Number:

R446.1

Figures/Tables 1

References 18

[1]	杨晓霞,杨衍涛,马莉,等. BNP、CRP、TNF-α、IL-6与慢性充血性心力衰竭的诊断和心功能分级相关性[J].兰州大学学报:医学版,2012,38(2):40-42.
[2]	廖予婕. cTnI、hs-CRP和BNP在心力衰竭患者治疗前后的变化及其对诊断和预后判断的价值[J]. 检验医学,2010,25(2):92-95.
[3]	应晓. B型钠尿肽在心力衰竭中的临床应用价值[J]. 检验医学,2010,25(4):317-318.
[4]	贺岩,李富荣,杜宗孝,等. 血清BNP、hs-CRP、cTnI及UA联合检测对心力衰竭的临床价值[J]. 检验医学,2012,27(8):647-650.
[5]	原永明,王慧,尹良平,等. 慢性心力衰竭患者BNP、hs-CRP水平检测的临床意义[J]. 检验医学,2015,30(6):591-592.
[6]	邵良荣,邵杰. 肺部感染患者血清降钙素原检测的临床应用[J]. 检验医学,2012,27(12):1093-1094.
[7]	鲁君艳,姜志刚,周维新,等. 血清降钙素原在儿童社区获得性肺炎诊断中的意义[J]. 检验医学,2013,28(1):40-43.
[8]	侯伟伟,肖倩茹,江涟,等. 血清降钙素原作为菌血症预示因子临床价值的研究[J]. 检验医学,2014,29(8):802-805.
[9]	慕月晶,王伟佳,严海忠,等. PCT检测在全身和局部细菌感染诊断中的临床应用[J]. 检验医学,2015,30(1):17-20.
[10]	刘桂香,商润萍,武燕敏. 降钙素原在重症监护室肺部感染早期诊断中的应用[J]. 检验医学,2015,30(2):203-205.
[11]	许程,徐元宏. 脓毒症早期预警生物标志物的研究进展[J]. 检验医学,2015,30(5):533-536.
[12]	钟倩怡,李招云,卢国光,等. 感染性标志物预测血流感染早期诊断价值的分析[J]. 检验医学,2015,30(5):522-524.
[13]	BRAUNWALD E.心脏病学[M].陈灏珠,译.5版.北京:人民卫生出版社,2003:407-411.
[14]	牟静飞. 婴幼儿肺炎并心力衰竭血清心肌酶谱检测的临床意义[J].中国临床新医学,2009,2(10):1069-1071.
[15]	陈志刚,秦瑞英,岳兵,等.心力衰竭患者肺部感染血浆脑钠肽、肿瘤坏死因子、白细胞介素6水平变化及意义[J]. 中华医院感染学杂志,2013,23(13):3054-3055.
[16]	田青,杨萍,王玮,等. 脑钠肽对心力衰竭诊断及预后评估的临床研究[J].中国心血管病研究,2010,8(3):167-171.
[17]	黄海军,徐华,陈凤娟. 早期脑钠肽测定对老年肺部感染性休克患者预后的临床意义[J].实用医学杂志,2011,27(18):3390-3391.
[18]	吴艳君,王俊.白介素-6与心力衰竭患者心肌重构的关系研究[J].中华全科医学,2014,12(3):378-379.

组别	例数	BNP(ng/L)	IL-6(ng/L)	PCT(μg/L)
患者组	116	456.87±52.67^*	34.67±7.21^*	3.89±1.32^*
NYHA-Ⅰ级	24	124.25±12.67	13.97±5.21	1.21±0.96
NYHA-Ⅱ级	27	243.76±31.67^#	27.38±3.57^#	2.24±0.76^#
NYHA-Ⅲ级	35	457.78±27.65^#▲	37.86±4.38^#▲	3.21±0.67^#▲
NYHA-Ⅳ级	30	589.38±42.96^#▲△	51.27±7.21^#▲△	4.38±0.82^#▲△
正常对照组	110	27.48± 6.21	3.25±0.41	0.42±0.14

组别	例数	BNP(ng/L)	IL-6(ng/L)	PCT(μg/L)
患者组	116	456.87±52.67^*	34.67±7.21^*	3.89±1.32^*
NYHA-Ⅰ级	24	124.25±12.67	13.97±5.21	1.21±0.96
NYHA-Ⅱ级	27	243.76±31.67^#	27.38±3.57^#	2.24±0.76^#
NYHA-Ⅲ级	35	457.78±27.65^#▲	37.86±4.38^#▲	3.21±0.67^#▲
NYHA-Ⅳ级	30	589.38±42.96^#▲△	51.27±7.21^#▲△	4.38±0.82^#▲△
正常对照组	110	27.48± 6.21	3.25±0.41	0.42±0.14

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 18

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.